GleamWall
中文EN

HIMS Hims & Hers Health, Inc.

Services-Offices & Clinics of Doctors of Medicine · NYSE · SEC CIK 1773751 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY29.8%
TTM net income YoY-242.6%
TTM EPS YoY-256.6%
Revenue 3-yr CAGR53.6%
Net income 3-yr CAGR—

Margins

Gross margin63.8%
Operating margin-8.1%
Net margin-6.7%
FCF margin0.3%
EBITDA margin-4.3%

Returns

ROE-40.8%
ROA-6.6%
ROIC (approx.)—
Asset turnover0.99x

Leverage & solvency

Liabilities / assets90.0%
Debt / equity0.00x
Current ratio0.92x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.94x
Accruals ratio-12.8%
Payout ratio—
Capex / revenue6.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$890.37M$753.21M$608.10M$617.82M$598.98M$544.83M$586.01M$481.14M
Cost of revenue$381.17M$272.41M$211.32M$173.38M$156.92M$128.64M$155.32M$111.60M
Gross profit$509.20M$480.80M$396.79M$444.44M$442.06M$416.20M$430.69M$369.54M
SG&A expense$151.48M$165.38M$109.67M$76.17M$80.68M$67.27M$48.61M$48.03M
Operating income-$66.15M-$97.19M-$78.32M$9.19M$11.81M$26.72M$57.90M$18.60M
Pretax income-$46.25M-$92.63M-$101.55M$18.35M$12.22M$32.85M$60.49M$22.29M
Income tax-$13.21M-$6.34M-$9.44M-$2.25M-$3.55M-$9.65M$11.01M-$3.73M
Net income-$33.04M-$86.29M-$92.11M$20.60M$15.77M$42.51M$49.48M$26.02M
EBITDA-$27.94M-$67.72M-$56.37M$27.28M$29.48M$37.19M$66.17M$24.66M
EPS (basic)-0.14-0.37-0.40—0.070.190.22—
EPS (diluted)-0.14-0.37-0.40—0.060.170.20—
Weighted avg. shares (diluted)233.82M231.75M228.36M—248.68M256.78M246.61M—
Balance sheet
Cash & equivalents$605.60M$609.81M$222.27M$228.62M$345.78M$1.12B$273.74M$221.44M
Short-term investments$106.62M$231.24M$528.61M$348.88M$283.97M$20.03M$48.94M$79.67M
Receivables$427.85M$375.29M$149.62M$32.15M———$6.10M
Inventory$107.85M$87.78M$79.07M$80.13M$105.99M$141.80M$76.10M$64.43M
Current assets$1.32B$1.38B$1.05B$767.64M$845.26M$1.36B$446.96M$395.83M
Goodwill$1.11B$1.10B$342.84M$278.32M$259.24M$117.75M$117.75M$112.73M
Intangibles$397.26M$422.81M$261.03M$196.12M$194.93M$40.66M$43.43M$43.41M
Total assets$3.55B$3.63B$2.27B$2.15B$2.23B$1.88B$891.71M$707.54M
Current liabilities$1.44B$1.48B$618.78M$404.43M$450.79M$272.23M$280.36M$221.37M
Total liabilities$3.19B$3.30B$1.82B$1.61B$1.65B$1.31B$342.45M$230.82M
Shareholders' equity$355.30M$324.07M$446.17M$540.93M$580.98M$562.70M$549.26M$476.72M
Cash flow statement
Operating cash flow$65.39M-$35.94M$89.36M$61.31M$148.72M-$19.12M$109.09M$86.39M
Capital expenditure$39.40M$32.30M$36.30M$63.90M$69.30M$50.40M$59.00M$26.90M
Free cash flow$25.99M-$68.24M$53.06M-$2.59M$79.42M-$69.52M$50.09M$59.48M
Investing cash flow-$55.42M$84.54M-$15.45M-$83.68M-$887.40M-$21.09M-$32.80M-$17.21M
Financing cash flow-$18.92M$341.76M-$77.88M-$97.52M-$39.01M$889.17M-$23.02M-$13.65M
Depreciation & amortization$38.21M$29.48M$21.95M$18.09M$17.67M$10.46M$8.28M$6.06M
Stock-based compensation$64.48M$42.12M$36.86M$34.49M$40.17M$35.73M$24.86M$24.35M
Share buybacks———$80.48M$9.48M$0$0$5.00M

Free plan shows the latest 8 periods; Pro shows all 30 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.